You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.


The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
 

You are reading 1 of 2 free-access articles allowed for 30 days

Irish research endorsed as a new approach to Heart Failure prevention in Canadian guidelines

By Mindo - 23rd Sep 2015 | 3 views

<p class=”p1″><span class=”s1″>Led by The Heartbeat Trust, the STOP-HF study used a simple blood test called natriuretic peptide to help identify those most at risk of heart failure. Natriuretic peptide is a protein released by the heart when it is under stress or strain. The research involved 1,350 participants from 39 GP practices in Ireland.</span>

<p class=”p2″>Participants with an elevated level of natriuretic peptide were given a heart ultrasound, lifestyle advice and reviewed by both their GP and cardiologist. As well as reducing repeated heart failure and hospital admissions for patients at high risk of cardiovascular disease, the researchers found that this approach reduced new onset of heart failure and significant heart dysfunction by 45 per cent and led to a reduction in hospital admissions for other major cardiovascular episodes such as heart attack or stroke by 40 per cent.

<p class=”p2″>The 2014 ‘Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: Anaemia, Biomarkers, and Recent Therapeutic Trial Implications’ now suggests that in individuals with risk factors for the development of heart failure that natriuretic peptide levels be used to implement strategies to prevent heart failure.  This is the first time that this approach has been recommended in international guidelines.

<p class=”p2″>Commenting on the development Prof Ken McDonald, Medical Director of The Heartbeat Trust and Principal Investigator, said, “This demonstrates how innovative, world-class research is important to everyday care of patients and that it can be performed in Ireland.”

<p class=”p2″>Dr Mark Ledwidge, Research Director of The Heartbeat Trust and Principal Investigator also commented, “This research importantly shows how personalised care to those most at risk can lead to better outcomes and allows the development of sustainable healthcare systems.”

<p class=”p2″>The STOP-HF study has received international recognition including presentation as a late breaking clinical trial at a American College of Cardiology conference, publication in the <em>Journal of the American Medical Association</em>, one of the world’s leading medical journals, and received the prestigious Royal College of General Practitioners Paper of the Year Award in 2014.

Leave a Reply

Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read